Elevance Health logged a -3.9% change during today's afternoon session, and is now trading at a price of $434.9 per share. The S&P 500 index moved -5.0%. ELV's trading volume is 3,319,022 compared to the stock's average volume of 1,659,127.
Elevance Health trades -12.7% away from its average analyst target price of $498.18 per share. The 19 analysts following the stock have set target prices ranging from $405.0 to $625.0, and on average have given Elevance Health a rating of buy.
If you are considering an investment in ELV, you'll want to know the following:
-
Elevance Health's current price is 41.9% above its Graham number of $306.52, which implies that at its current valuation it does not offer a margin of safety
-
Elevance Health has moved -10.8% over the last year, and the S&P 500 logged a change of 3.7%
-
Based on its trailing earnings per share of 25.67, Elevance Health has a trailing 12 month Price to Earnings (P/E) ratio of 16.9 while the S&P 500 average is 29.3
-
ELV has a forward P/E ratio of 12.4 based on its forward 12 month price to earnings (EPS) of $34.95 per share
-
Its Price to Book (P/B) ratio is 2.39 compared to its sector average of 3.53
-
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
-
Based in Indianapolis, the company has 104,200 full time employees and a market cap of $98.46 Billion. Elevance Health currently returns an annual dividend yield of 1.4%.
